SCHEMBL2223948

SCHEMBL2223948

COc1ccc(CNC(=O)CC2CCN(c3ncc(S(C)(=O)=O)cc3NC(=O)c3cccc(Cl)c3)CC2)cc1.Cc1cccc(C)c1NC(=O)CC1CCN(c2ncc(S(C)(=O)=O)cc2NC(=O)c2cccc(Cl)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 2/20 0.43
ALDH1A1 P00352 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
ATM Q13315 2/20 0.38
P2RY12 Q9H244 1/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
LMNA P02545 2/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37
ACKR3 P25106 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KCNH2 Q12809 1/20 0.36
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2270555 0.95 CXCR3 (0.47) CXCR3ALDH1A1SMN1; SMN2KDM4EPOLB
SCHEMBL2277751 0.90 CXCR3 (0.51) CXCR3ALDH1A1SMN1; SMN2ATMKMT2A
SCHEMBL2270467 0.89 ALDH1A1 (0.47) CXCR3ALDH1A1ATMKMT2ALMNA
SCHEMBL2276600 0.89 CXCR3 (0.49) CXCR3SMN1; SMN2ATMKMT2AMEN1
SCHEMBL2275511 0.87 CXCR3 (0.49) CXCR3ALDH1A1SMN1; SMN2ATMLMNA
SCHEMBL2273750 0.87 CXCR3 (0.49) CXCR3SMN1; SMN2POLBKMT2ALMNA
SCHEMBL2269654 0.85 CXCR3 (0.48) CXCR3ALDH1A1SMN1; SMN2ATMP2RY12
SCHEMBL16448962 0.85 CXCR3 (0.48) CXCR3SMN1; SMN2POLBATMP2RY12
SCHEMBL2268876 0.85 CXCR3 (0.48) CXCR3SMN1; SMN2ATMP2RY12KMT2A
SCHEMBL16448963 0.85 CXCR3 (0.47) CXCR3ALDH1A1SMN1; SMN2ATMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011084985-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-14 WO disclosed